Technical Analysis for PTX - Pernix Therapeutics Holdings, Inc.

Grade Last Price % Change Price Change
grade F 0.4 -2.44% -0.01
PTX closed down 2.44 percent on Friday, January 18, 2019, on 28 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PTX trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Resistance Bearish 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Fell Below 20 DMA Bearish -2.44%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.44%
Jan 17 Inside Day Range Contraction -2.44%
Jan 17 Wide Bands Range Expansion -2.44%
Jan 16 20 DMA Support Bullish -6.98%
Jan 16 Pocket Pivot Bullish Swing Setup -6.98%
Jan 16 Wide Bands Range Expansion -6.98%
Jan 15 Crossed Above 20 DMA Bullish -4.76%

Older signals for PTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pernix Therapeutics Holdings, Inc. focuses on developing, manufacturing, marketing, and selling branded and generic pharmaceutical products for pediatric and adult indications in various therapeutic areas. Its products include CEDAX, a oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogenes; NATROBA, a prescription medicine used to treat head lice in adults and children; and VERIPRED, a prescription drug product for the control of allergic conditions in adult and pediatric populations with seasonal or perennial allergic rhinitis, asthma, contact and atopic dermatitis, serum sickness, and drug hypersensitivity reactions. The company's products also comprise OMECLAMOX-PAK for the treatment of patients with H.pylori infection and duodenal ulcer disease; REZIRA and ZUTRIPRO, which are oral solutions for the relief of cough and nasal congestion; SILENOR, a prescription medicine used to treat insomnia characterized by difficulty with sleep maintenance; REPREXAIN for the short-term management of acute pain; REZYST, a proprietary probiotic blend to promote the dietary management; and prescription drugs for cough and cold under the BROVEX, ALDEX, and PEDIATEX names. In addition, it offers various generic pharmaceutical products in the areas of nutritional supplements, analgesics, urinary tract, women's health, prenatal vitamins, and dental health, as well as iron deficiency and nephrology. Further, the company, through its joint venture agreement with SEEK, is developing BC 1036, an antitussive cough suppressant pharmaceutical product. Additionally, it is developing a prescription product for the pediatrics market. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was incorporated in 1996 and is headquartered in The Woodlands, Texas.
Is PTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.3
52 Week Low 0.27
Average Volume 670,469
200-Day Moving Average 1.4988
50-Day Moving Average 0.4724
20-Day Moving Average 0.4144
10-Day Moving Average 0.4295
Average True Range 0.0709
ADX 26.51
+DI 21.2766
-DI 15.2264
Chandelier Exit (Long, 3 ATRs ) 0.2773
Chandelier Exit (Short, 3 ATRs ) 0.5227
Upper Bollinger Band 0.4798
Lower Bollinger Band 0.349
Percent B (%b) 0.39
BandWidth 31.563707
MACD Line -0.0128
MACD Signal Line -0.0173
MACD Histogram 0.0045
Fundamentals Value
Market Cap 4.45 Million
Num Shares 11.1 Million
EPS -16.97
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 0.23
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.48
Resistance 3 (R3) 0.48 0.47 0.46
Resistance 2 (R2) 0.47 0.45 0.46 0.46
Resistance 1 (R1) 0.43 0.44 0.43 0.43 0.45
Pivot Point 0.42 0.42 0.41 0.41 0.42
Support 1 (S1) 0.38 0.40 0.38 0.38 0.35
Support 2 (S2) 0.37 0.39 0.36 0.34
Support 3 (S3) 0.33 0.37 0.34
Support 4 (S4) 0.33